-
Soft launch of Sputnik V vaccine reaches over 50 cities and towns, after initial launch in Hyderabad on May 14
-
Over 38.60 crore vaccine doses have been provided to states and UTs so far through all sources and a further 11,25,140 doses are in the pipeline.
-
More than 38.54 crore (38,54,01,150) vaccine doses have been provided to States/UTs so far, through all sources. Of this, the total consumption including wastages is 36,80,68,124 doses
-
The Union Health Ministry on Thursday projected that it will be able to supply 27,99,290 doses to Telangana in July.
-
With the delta variant, a study by British researchers found people were well protected when they got both doses of either the AstraZeneca or Pfizer-BioNTech vaccines.
-
Out of estimated 59.7 crore people in the age group of 18-44 years, about 15% have been vaccinated with the first dose of the vaccine
-
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik
-
China earlier this month, authorised the emergency use of CoronaVac, for children aged between 3 and 17 years.
-
The UK-based competition is investing a £5.7 million ($8 million) charitable pledged prize fund into one grand prize winner, two second prize winners, and five third prize winners.
-
Additional Chief Secretary (Health) Dr Pradeep Vyas said Maharashtra, till Thursday, had administered 2,97,23,951 doses.
-
Public and private partners in Abu Dhabi are developing capacity to transport, store, and distribute 18 billion Covid-19 vaccine doses per annum to countries around the world
-
India's cumulative Covid vaccination coverage was recorded at over 28.33 crore since January 16, according to the data from the CoWIN portal.
-
The vaccination drive, with focus on people over the age of 45 years and mothers with children under five years, began at 6 AM in more than 2,000 locations in all 13 districts of the State.
-
The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.
-
Drug pricing regulator says companies must pass on the benefit to customers.
-
Being a limited pilot phase presently, registration on CoWIN is not open yet to public, but will become open at the time of commercial launch.
-
New Delhi: The National Council of Science Museums (NCSM) and Science Museum Group, London have joined hands to launch an international exhibition ‘Hunt for the Vaccine’ on wheels which will tour five venues in India to tell the story of the global effort in developing vaccines to curb the pandemic. The tour includes four metro […]
-
Centre has decided to buy 75 per cent of jabs from vaccine makers, including 25 per cent of the state quota, and give it for free to state governments, the prime minister said
-
Sinovac has finished the Phrase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved that the vaccine is as safe and efficient.
-
The implementation of the "Liberalized and Accelerated Phase-III Strategy of COVID-19 Vaccination" has started on May 1, 2021.